Resolve Therapeutics' Series A Round

Resolve Therapeutics raised a round of funding on May 11, 2011.

Resolve Therapeutics is a private biotechnology company focusing on the advancement of a biologic compound, RSLV-125 from preclinical research through a phase IIa clinical trial to improve the lives o…

Articles about Resolve Therapeutics' Series A Round: